MRI imaging appears to hold good value in monitoring patients who have been originally treated (i.e. radiation, chemo) for more localized colorectal cancer (i.e. stage II, III) and who have not received surgery but rather a watch and wait approach (i.e. active surveillance). Those patients who had the better responses (i.e. complete response) to the initial treatment had the better 5 year disease-free survival. It is good to see how MRI used in this area can be predictive of survival, rise of cancer recurrence, and the ability to keep or preserve the bowel. Some patients who have chosen this path can find further comfort on the use of MRI in the monitoring process which should also include periodic endoscopy evaluations as well to make sure.
MRI Predicts Residual Disease and Outcomes in Watch and Wait Patients with Rectal Cancer
Discuss what this means for you
Research can raise useful questions. A study or individual case report does not establish that a treatment is suitable for everyone. Discuss medications, supplements and treatment changes with your care team.
Talk with our team